Previous molecular studies of LN report a robust IFN response as the key feature distinguishing kidneys of lupus patients from healthy individuals and the TGN stage is when we first observed significant enrichment of an IFN signature in glomeruli of diseased mice (33–35). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.